Vanguard Group Inc. lowered its stake in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 2.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,912,703 shares of the company's stock after selling 63,777 shares during the quarter. Vanguard Group Inc. owned approximately 5.79% of Enhabit worth $22,748,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. FMR LLC raised its position in shares of Enhabit by 138.4% during the 3rd quarter. FMR LLC now owns 3,388 shares of the company's stock valued at $27,000 after acquiring an additional 1,967 shares in the last quarter. Quantbot Technologies LP bought a new stake in Enhabit during the fourth quarter valued at $45,000. Corient Private Wealth LLC acquired a new stake in shares of Enhabit during the fourth quarter worth $79,000. Stoneridge Investment Partners LLC lifted its position in shares of Enhabit by 22.6% in the 4th quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company's stock worth $98,000 after buying an additional 2,308 shares during the last quarter. Finally, Intech Investment Management LLC grew its position in shares of Enhabit by 27.6% during the 4th quarter. Intech Investment Management LLC now owns 15,481 shares of the company's stock valued at $121,000 after buying an additional 3,353 shares during the last quarter.
Analyst Ratings Changes
Separately, Jefferies Financial Group reissued a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.
Check Out Our Latest Stock Report on EHAB
Enhabit Stock Performance
Shares of EHAB stock traded down $0.03 during trading hours on Friday, reaching $7.68. The stock had a trading volume of 243,215 shares, compared to its average volume of 483,756. The firm has a market capitalization of $387.43 million, a PE ratio of -3.31 and a beta of 1.60. The firm has a 50-day simple moving average of $8.42 and a 200-day simple moving average of $8.00. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $10.70. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46.
Enhabit Profile
(
Free Report)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Further Reading
Before you consider Enhabit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.
While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
